Kapoian Toros, Meyer Klemens B, Johnson Douglas S
Associate Professor of Medicine, Rutgers-Robert Wood Johnson Medical School, Department of Medicine, Division of Nephrology New Brunswick, New Jersey; Medical Director, Dialysis Clinic, Inc., North Brunswick, New Jersey;
Professor of Medicine, Division of Nephrology, Tufts University School of Medicine, Medford, Massachusetts; Director, Dialysis Services, Tufts Medical Center, Boston, Massachusetts; and.
Clin J Am Soc Nephrol. 2015 May 7;10(5):863-74. doi: 10.2215/CJN.06050614. Epub 2015 Feb 20.
Infections continue to be a major cause of disease and contributor to death in patients on dialysis. Despite our knowledge and acceptance that hemodialysis catheters should be avoided and eliminated, most patients who begin dialysis initiate treatment through a central vein hemodialysis catheter. Dialysis Medical Directors must be the instrument through which our industry changes. We must lead the charge to educate our dialysis staff and our dialysis patients. We must also educate ourselves so that we not only know that our facility policies are consistent with the best evidence available, but we must also know where local and federal regulations differ. When these differences impact on patient care, we must speak out and have these regulations changed. But it is not enough to know the rules and write them. We must lead by example and show our patients, our nephrology colleagues and our dialysis staff that we always follow these same policies. We need to practice what we preach and be willing and available to redirect those individuals who have difficulty following the rules. In order to effectively change process meaningful data must be collected, analyzed and acted upon. Dialysis Medical Directors must direct and lead the quality improvement process. We hope this review provides Dialysis Medical Directors with the necessary tools to effectively drive this process and improve care.
感染仍然是透析患者发病和死亡的主要原因。尽管我们了解并认可应避免和消除血液透析导管,但大多数开始透析的患者都是通过中心静脉血液透析导管开始治疗的。透析医疗主任必须成为推动我们行业变革的工具。我们必须带头对透析工作人员和透析患者进行教育。我们自己也必须接受教育,这样我们不仅要知道我们机构的政策与现有最佳证据一致,而且还必须了解地方和联邦法规的差异所在。当这些差异影响患者护理时,我们必须发声并促使这些法规得到修改。但仅仅了解规则并制定规则是不够的。我们必须以身作则,向我们的患者、肾病学同事和透析工作人员表明,我们始终遵循这些相同的政策。我们需要言行一致,愿意并能够引导那些难以遵守规则的人。为了有效地改变流程,必须收集、分析有意义的数据并据此采取行动。透析医疗主任必须指导和引领质量改进过程。我们希望这篇综述为透析医疗主任提供必要的工具,以有效地推动这一过程并改善护理。